Cadrenal Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Cadrenal Therapeutics filed an S-1 registration statement for the resale of 428,227 common shares underlying warrants from a recent private placement and registered direct offering.